Sanofi (SNYNF) Acquisitions (2023 - 2026)

Sanofi (SNYNF) posted Acquisitions of -$2.0 billion for Q1 2026, up 84.41% sequentially from -$12.8 billion in Q4 2025.

Sanofi (SNYNF) Acquisitions (2023 - 2026) Analysis & Trends

Sanofi has reported Acquisitions for 4 years, with the latest figure at -$2.0 billion in Q1 2026.

Quarterly Acquisitions changed N/A year-over-year to -$2.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.6 billion (changed N/A YoY) and the FY2025 annual result came in at -$12.8 billion, down 377.35% from the prior year.
Acquisitions grew to -$2.0 billion in Q1 2026 per SNYNF's latest filing, from -$12.8 billion in the prior quarter.
Over five years, Acquisitions peaked at -$90.2 million in Q1 2024 and troughed at -$12.8 billion in Q4 2025.
A 4-year average of -$4.2 billion and a median of -$2.7 billion in 2024 frame the typical range for Acquisitions.
The sharpest annual moves came in 2024 and 2025: Acquisitions climbed 20.87% in 2024, then tumbled 376.97% in 2025.
Over 4 years, Acquisitions stood at -$3.4 billion in 2023, then gained by 20.87% to -$2.7 billion in 2024, then sank by 376.97% to -$12.8 billion in 2025, then jumped by 84.41% to -$2.0 billion in 2026.
According to Business Quant data, Acquisitions over the past three periods registered -$2.0 billion, -$12.8 billion, and -$2.7 billion for Q1 2026, Q4 2025, and Q4 2024 respectively.

Download Data